Prevalence of chronic diabetes complications in dependence on insulin therapy method in children and adolescens with type 1 diabetes;Wystȩpowanie powikłań przewlekłych w cukrzycy typu 1 u dzieci i młodzieży w zależności od metody insulinoterapii

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 10, Issue 1, 2004, Pages 31-39

  Florys, Bozena ^a   Ołdyłowska, Agnieszka ^a   Głowińska, Barbara ^a   Peczyńska, Jadwiga ^a   Urban, Mirosława ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Children and adolescens; Chronic complications; Diabetes mellitus type 1; Insulin therapy

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADOLESCENT; ARTICLE; CATARACT; CHILD; CHRONIC DISEASE; CORRELATION ANALYSIS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; ADULT; DRUG ADMINISTRATION; INJECTION; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CATARACT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS; INSULIN; MALE; PREVALENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 3543050619     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ahern J.A., Ramchandani N., Cooper J. i wsp.: Using a primary nurse manager to implement DCCT recommendations in a large pediatric program. Diabetes Educ., 2000, 26, 990.
2. American Diabetes Association: Diabetic nephropathy. Diabetes Care, 1999, 22, supl. 1, 66.
3. Chase H.P., Lockspeiser T., Peery B. i wsp.: The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care, 2001, 24, 430.
4. DCCT/EDIC Research Group: Retinopathy and nephropathy in patients with type 1 diabetes - four years trial of intensive therapy. N. Engl. J. Med., 2000, 342, 381.
5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med., 2000, 342, 381.
6. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes meellitus. N. Engl. J. Med., 1993, 329, 977.
7. Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care, 1999, 22, 99.
8. Iwanicka Z. i wsp.: Wystȩpowanie neuropatii u pacjentów z cukrzyca̧ typu 1. Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego, 2000, 6, 93.
9. Kowalewski M., Urban M.: The influence of upright position on heart rate variability parameters in adolescents with hypertension and type 1 diabetes. Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego, 2001, 7, 95.
10. Kowalewski M.A., Urban M., Florys B., Peczynska J.: Late potentials: are they related to cardiovascular complications in children with type 1 diabetes? J. Diabetes Complications, 2002, 16, 263.
11. Krolewski A.S., Fogarty D.G., Warram J.H.: Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? Diabetes Res. Clin. Pract., 1998, 39, supl., S1.
12. Lawson M.L., Gerstein H.C., Tusui E., Zinman B.: Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diabetes Care, 1999, 22, supl. 2, B35-B39.
13. Malone J.I., Morrison A.D., Pavan P.R., Cuthbertson D.D.: Diabetes Control and Complications Trial: prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care, 2001, 24, 522.
14. Noczyńska A.: Współczesne metody insulinoterapii cukrzycy typu 1 w wieku rozwojowym, Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego, 2001, 7, 33.
15. Service F.J., O'Brien P.C.: The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia, 2001, 44, 1215.
16. Sieradzki J.: Przewlekłe powikłania cukrzycy. Fundacja Rozwoju Diagnostyki Laboratoryjnej. Kraków, 1998, 87, 93.
17. Szadkowska A. i wsp.: Albuminuria u dzieci i młodzieży z cukrzyca̧ typu 1. Przegl. Pediatr., 2002, 32, 126.
18. Thomas W., Shen Y., Molith M.E., Steffes M.W.: Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial. J. Am. Soc. Nephrol., 2001, 12, 333.
19. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 1998, 352, 854.
20. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837.
21. White N.H., Cleary P.A., Dahms W. i wsp.: Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J. Pediatr., 2001, 139, 804.